Scarica l'app Stockscreener
0.7711
8.19%
-0.0688
Precedente Chiudi:
$0.8399
Aprire:
$0.857199
Volume 24 ore:
33,410
Relative Volume:
0.12
Capitalizzazione di mercato:
$31.25M
Reddito:
$3.99M
Utile/perdita netta:
$-3.55M
Rapporto P/E:
-1.3997
EPS:
-0.5509
Flusso di cassa netto:
$94,500
1 W Prestazione:
+0.55%
1M Prestazione:
+3.60%
6M Prestazione:
-46.45%
1 anno Prestazione:
-56.68%
Intervallo 1D:
$0.7392
$0.8572
Intervallo di 1 settimana:
$0.7112
$0.8688
Portata 52W:
$0.3818
$2.0299
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Nome
China Pharma Holdings Inc.
Settore
Telefono
86 898 6681 1730
Indirizzo
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.7711 | 31.25M | 3.99M | -3.55M | 94,500 | -0.5509 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2010-01-08 | Iniziato | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Borsa (CPHI) Ultime notizie
China Pharma Holdings Inc (CPHI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China Pharma Holdings Inc (CPHI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China Pharma Holdings Inc (CPHI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
China Pharma Holdings Inc (CPHI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China Pharma Holdings Inc (CPHI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China Pharma Holdings Inc (CPHI) Institutional Confidence - TradingKey
China Pharma Holdings Inc (CPHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China Pharma Holdings Inc (CPHI) Valuation: PE, PB & Fair Value Analysis - TradingKey
China Pharma Holdings Inc (CPHI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
World Gel Matrix Transdermal SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Chewy Reports Strong FQ1 2026 Results; Analysts Highlight Mid-Cap Growth PotentialProduct Revenue Analysis - newsline.com
AMC Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts Investor SentimentGuidance Accuracy Score - newsline.com
Japanese Pharma Giants Look to China for Drug Discovery and Growth OpportunitiesEarnings Surprise Stocks - newsline.com
Shanghai Fosun Pharmaceutical Stock (CNE100000536): shares in focus amid quiet news flow - AD HOC NEWS
CPHI Q3 2011 Earnings: Significant EPS Miss Amid Challenging QuarterRevenue Report - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Amid Challenging QuarterEarnings Trend Analysis - newsline.com
OGE Energy Slips 2.9%: Defensive Utility Faces Technical HeadwindsBreakout Confirmation - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Significantly, Stock DeclinesMargin Improvement Report - newsline.com
Arrowhead Pharmaceuticals Q1 2026 Earnings: EPS Surprise on Lower Expenses Offsets Revenue VoidDividend Increase Stocks - newsline.com
Marvell Technology and Flex Set to Join S&P 500, Replacing Pool and Campbell’sPost-Announcement Reaction - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates, Stock Declines 12.9%Earnings Volatility Report - newsline.com
May Jobs Report Expected to Show Slower Hiring: Reality Check for Strong StartGross Profit Margin - newsline.com
US lawmakers reveal policy to curb collaboration with Chinese biotech - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CPHI Q3 2011 Earnings: EPS Misses Estimates Despite Strong Stock RallyRevenue Growth Outlook - newsline.com
China Pharma Holdings (CPHI) Holds Steady at $0.79 as Key Support and Resistance Levels Remain in FocusProfitability Factor - The Legal Advocate
China NT Pharma Group Announces Proposed Disposal of NT Pharma (Overseas) Holding Co., Ltd Equity Interests to Alleviate Liquidity Strain 12 - Minichart
KOP Q1 2026 Earnings: EPS Surprises by Nearly 30% Amid Revenue Silence, Stock SlipsEstimate Uncertainty - The Legal Advocate
symbol__ Stock Quote Price and Forecast - CNN
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Udemy Inc. (UDMY) Stabilizes Near Support as Market Awaits CatalystChandelier Stop - The Legal Advocate
China Pharma Company Profile & Introduction - Moomoo
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says - Yahoo Finance
CRB-701 Phase 1/2 data outlines next steps, Corbus Pharmaceuticals Holdings, Inc. - Traders Union
Plasma Fractionation Market Size, Share, Growth, Analysis, 2034 - Straits Research
China Pharma Holdings (CPHI) Q3 2011 Earnings: EPS Miss Weighs on SentimentEPS Guidance Update - newsline.com
CPHI Q3 2011 Earnings: EPS Falls Short of Consensus Amid Operational HeadwindsPerformance Review - newsline.com
Rafael Holdings (RFL) Sees Modest Uptick, Testing Key Resistance at $1.41MA Cross Alert - The Legal Advocate
CPHI Stock Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
Trump's China Visit: US CEOs Musk, Cook and Nvidia’s Huang Join Trade TalksEarnings Forecast Report - newsline.com
China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
South Korea’s Reversal on AI Tax Proposal Seen as Positive Signal for Micron (MU) StockShare Dilution Risk - newsline.com
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity - digitalmore.co
China Pharma says unaware of reason for unusual trading - Investing.com
China Pharma says unaware of reason for unusual trading By Investing.com - Investing.com Nigeria
China Pharma Holdings IncNYSE American contacts China Pharma regarding unusual market activity on May 12 and 13 - marketscreener.com
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
TradingKey - TradingKey
These stocks are moving in today's after hours session - ChartMill
C3 AI Announces Q4 and Fiscal Year 2026 Preliminary Results: Tom Siebel Returns as CEO, Reports Revenue Within Guidance and Improved Operating Losses - Minichart
China Pharma Holdings Inc. Azioni (CPHI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
11.23%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):